XFOR
X4 Pharmaceuticals Inc
2.90$
+0.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -25.0% | -35.0% | -47.2% | +0.0% | +1,094.2% | +53.8% | -72.9% | -18.3% | +90.0% | +60.4% | |
| – | +411.1% | +40.7% | +520.3% | -63.5% | +164.8% | +13.9% | -15.9% | +67.1% | -5.6% | -47.6% | |
| – | – | -136.2% | – | +60.7% | -9.7% | +197.1% | -68.1% | – | – | – | |
| – | -135.7% | – | -8.4% | -203.2% | – | – | – | -94.0% | +677.6% | -196.3% | |
| – | -57.1% | -42.5% | -19.0% | +411.8% | +682.8% | -54.8% | -83.3% | -41.7% | +12,110.0% | -59.0% | |
| – | -44.1% | -69.6% | -19.0% | – | -105.0% | -54.8% | -83.3% | +14,349.5% | – | -87.8% | |
| – | – | – | – | – | -37.9% | +12.6% | -100.0% | – | – | – | |
| – | +625.0% | +126.4% | +471.6% | – | -101.4% | +622.0% | -100.0% | -100.0% | – | – | |
| – | – | +0.0% | -41.2% | -86.4% | +2,475.5% | -100.0% | – | – | -2.1% | -100.0% | |
| – | +57.7% | +458.0% | -93.2% | +1,947.5% | -91.2% | +499.0% | +57.9% | -24.5% | -77.1% | +1,075.9% | |
| – | -155.1% | – | -193.1% | – | -139.5% | – | +1,318.1% | -157.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.